BindingDB logo
myBDB logout

BDBM328032 N-(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)pyridin-2- yl)biphenyl-4- carboxamide::US10377742, Compound 170::US9663496, Compound 170

SMILES: Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(NC(=O)c3ccc(cc3)-c3ccccc3)nc2)cc1

InChI Key: InChIKey=RVMRUZKLKWZPBU-UHFFFAOYSA-N

Data: 2 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 328032   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
5'-AMP-activated protein kinase catalytic subunit alpha-2


(Homo sapiens (Human))
BDBM328032
PNG
(N-(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)py...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(NC(=O)c3ccc(cc3)-c3ccccc3)nc2)cc1
Show InChI InChI=1S/C30H27FN4O2/c31-27-13-6-22(7-14-27)21-34-16-18-35(19-17-34)30(37)26-12-15-28(32-20-26)33-29(36)25-10-8-24(9-11-25)23-4-2-1-3-5-23/h1-15,20H,16-19,21H2,(H,32,33,36)
PDB

Reactome pathway

UniProtKB/SwissProt

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US10377742 (2019)


BindingDB Entry DOI: 10.7270/Q2RV0R22
More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM328032
PNG
(N-(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)py...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(NC(=O)c3ccc(cc3)-c3ccccc3)nc2)cc1
Show InChI InChI=1S/C30H27FN4O2/c31-27-13-6-22(7-14-27)21-34-16-18-35(19-17-34)30(37)26-12-15-28(32-20-26)33-29(36)25-10-8-24(9-11-25)23-4-2-1-3-5-23/h1-15,20H,16-19,21H2,(H,32,33,36)
PDB

Reactome pathway

UniProtKB/SwissProt

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Rigel Pharmaceuticals, Inc

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)


BindingDB Entry DOI: 10.7270/Q26975P8
More data for this
Ligand-Target Pair